Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Survey quantifies COVID-19’s impact on oncology

Key clinical point: An international survey provides new insights into how COVID-19 has affected, and may continue to affect, the field of oncology.

Major finding: About 82% of oncologists surveyed said they were likely to continue the use of telemedicine in the future, but 45% said virtual international conferences are not an acceptable alternative to live conferences.

Study details: A survey of 109 oncologists in 18 countries, with answers recorded between June 17 and July 14, 2020.

Disclosures: The research was funded by Fondation Léon Fredericq. Dr. Jerusalem disclosed relationships with Novartis, Roche, Lilly, Pfizer, Amgen, Bristol-Myers Squibb, AstraZeneca, Daiichi Sankyo, AbbVie, MedImmune, and Merck.


Jerusalem G et al. ESMO 2020, Abstract LBA76_PR.